References
- Reed, L. J. Acc. Chem. Res. 1974, 7, 40. https://doi.org/10.1021/ar50074a002
- Walker, J. L.; Oliver, D. J. J. Biol. Chem. 1986, 261, 2214.
- Brautigam, C. A.; Chuang, J. L.; Tomchick, D. R.; Machius, M.; Chuang, D. T. J. Mol. Biol. 2005, 350, 543. https://doi.org/10.1016/j.jmb.2005.05.014
- Cameron, J. M.; Levandovskiy, V.; Mackay, N.; Raiman, J.; Renaud, D. L.; Clarke, J. T.; Feigenbaum, A.; Elpeleg, O.; Robinson, B. H. Am. J. Med. Genet. 2006, 140, 1542.
- Kim, H.; Patel, M. S. J. Biol. Chem. 1992, 267, 5128.
- Kim, H. Bull. Korean Chem. Soc. 2007, 28, 907. https://doi.org/10.5012/bkcs.2007.28.6.907
- Karim, M.; Shim, M.-Y.; Kim, J.; Choi, K.-J.; Kim, J.-R.; Choi, J.-D.; Yoon, M.-Y. Bull. Korean Chem. Soc. 2006, 27, 549. https://doi.org/10.5012/bkcs.2006.27.4.549
- Koh, J.-U.; Cho, H.-Y.; Kong, K.-H. Bull. Korean Chem. Soc. 2007, 28, 772. https://doi.org/10.5012/bkcs.2007.28.5.772
- Park, S. H.; Kim, B. G.; Lee, S. H.; Lim, Y.; Cheong, Y.; Ahn, J.-H. c. 2007, 28, 2248. https://doi.org/10.5012/bkcs.2007.28.12.2248
- Quyen, D. V.; Ha, S. C.; Kim, D.; Lee, S.; Park, S.-J.; Kim, K. K.; Kim, Y.-G. Bull. Korean Chem. Soc. 2007, 28, 2539. https://doi.org/10.5012/bkcs.2007.28.12.2539
Cited by
- Characterization of Two Site-Specifically Modified Human Dihydrolipoamide Dehydrogenase Mutants (Pro-282 to Ala and Pro-298 to Ala) vol.33, pp.4, 2012, https://doi.org/10.5012/bkcs.2012.33.4.1119
- Characterization of a Naturally Occurring Mutation (Ile-358 to Thr) in Human Dihydrolipoamide Dehydrogenase of a Patient with Leigh Syndrome vol.33, pp.5, 2012, https://doi.org/10.5012/bkcs.2012.33.5.1445
- Characterization of Two Site-specific Mutations in Human Dihydrolipoamide Dehydrogenase vol.34, pp.6, 2013, https://doi.org/10.5012/bkcs.2013.34.6.1621
- Characterization of Site-specific Mutations in Human Dihydrolipoamide Dehydrogenase Significantly Destabilizing the Transition State of the Enzyme Catalysis vol.59, pp.4, 2015, https://doi.org/10.5012/jkcs.2015.59.4.344
- Characterization of a Naturally Occurring Mutation (Arg-447 to Gly) in Human Dihydrolipoamide Dehydrogenase of Patients with Neurological Deterioration vol.60, pp.1, 2016, https://doi.org/10.5012/jkcs.2016.60.1.88
- Characterization of Two Site-specifically Mutated Human Dihydrolipoamide Dehydrogenase (Leu-46 to Ala and Pro-52 to Val) vol.30, pp.9, 2009, https://doi.org/10.5012/bkcs.2009.30.9.2121
- Characterization of a Naturally Occurring Mutation (Arg-460 to Gly) Close to FAD in Human Dihydrolipoamide Dehydrogenase vol.31, pp.12, 2010, https://doi.org/10.5012/bkcs.2010.31.12.3511
- Characterization of Human Cytosolic Thioredoxin Reductase by Site-specific Mutagenesis vol.31, pp.12, 2010, https://doi.org/10.5012/bkcs.2010.31.12.3515
- Characterization of Three Site-specific Mutations in Human Dihydrolipoamide Dehydrogenase (Gly-42 to Ala, Gly-43 to Ala and Val-48 to Trp) vol.32, pp.12, 2009, https://doi.org/10.5012/bkcs.2011.32.12.4427
- Characterization of Two Naturally Occurring Mutations (Gly-101 Deletion and Glu-340 to Lys Substitution) in Human Dihydrolipoamide Dehydrogenase of a Patient with Metabolic Acidosis vol.33, pp.8, 2012, https://doi.org/10.5012/bkcs.2012.33.8.2477
- Characterization of Site-Specific Mutations Affecting the Catalytic Efficiency of Human Dihydrolipoamide Dehydrogenase toward NAD+ vol.59, pp.2, 2009, https://doi.org/10.5012/jkcs.2015.59.2.183
- Characterization of Two Site-Specific Mutations in Human Dihydrolipoamide Dehydrogenase Deteriorating the Apparent Enzyme Binding Affinities to Both Dihydrolipoamide and NAD+ vol.62, pp.3, 2009, https://doi.org/10.5012/jkcs.2018.62.3.253